PL3166945T3 - Nowe pochodne triazolopirymidynonu lub triazolopirydynonu i ich zastosowanie - Google Patents

Nowe pochodne triazolopirymidynonu lub triazolopirydynonu i ich zastosowanie

Info

Publication number
PL3166945T3
PL3166945T3 PL15818399T PL15818399T PL3166945T3 PL 3166945 T3 PL3166945 T3 PL 3166945T3 PL 15818399 T PL15818399 T PL 15818399T PL 15818399 T PL15818399 T PL 15818399T PL 3166945 T3 PL3166945 T3 PL 3166945T3
Authority
PL
Poland
Prior art keywords
triazolopyrimidinone
novel
triazolopyridinone
derivatives
triazolopyridinone derivatives
Prior art date
Application number
PL15818399T
Other languages
English (en)
Inventor
Jung Nyoung Heo
Hwan Jung LIM
Kwang Rok Kim
Kyung Jin Kim
Uk II KIM
Hyung Tae Bang
Ji Hye Yoon
Original Assignee
St Pharm Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St Pharm Co., Ltd. filed Critical St Pharm Co., Ltd.
Priority claimed from PCT/KR2015/007219 external-priority patent/WO2016006974A2/en
Publication of PL3166945T3 publication Critical patent/PL3166945T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Epidemiology (AREA)
PL15818399T 2014-07-11 2015-07-10 Nowe pochodne triazolopirymidynonu lub triazolopirydynonu i ich zastosowanie PL3166945T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR20140087798 2014-07-11
KR1020150068375A KR101739003B1 (ko) 2014-07-11 2015-05-15 신규한 트리아졸로피리미디논 또는 트리아졸로피리디논 유도체, 및 이들의 용도
PCT/KR2015/007219 WO2016006974A2 (en) 2014-07-11 2015-07-10 Novel triazolopyrimidinone or triazolopyridinone derivatives, and use thereof
EP15818399.6A EP3166945B1 (en) 2014-07-11 2015-07-10 Novel triazolopyrimidinone or triazolopyridinone derivatives, and use thereof

Publications (1)

Publication Number Publication Date
PL3166945T3 true PL3166945T3 (pl) 2020-09-07

Family

ID=55308036

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15818399T PL3166945T3 (pl) 2014-07-11 2015-07-10 Nowe pochodne triazolopirymidynonu lub triazolopirydynonu i ich zastosowanie

Country Status (10)

Country Link
US (1) US9914737B2 (pl)
EP (1) EP3166945B1 (pl)
JP (1) JP6257835B2 (pl)
KR (1) KR101739003B1 (pl)
CN (1) CN106488918B (pl)
DK (1) DK3166945T3 (pl)
ES (1) ES2763566T3 (pl)
HU (1) HUE048394T2 (pl)
PL (1) PL3166945T3 (pl)
PT (1) PT3166945T (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7369968B2 (ja) * 2017-12-27 2023-10-27 公益財団法人がん研究会 抗がん剤
EP3787630A4 (en) 2018-04-30 2022-01-26 Indiana University Research and Technology Corporation FERROCHELATASE INHIBITORS AND METHODS OF USE
US20240317737A1 (en) * 2021-01-11 2024-09-26 St Pharm Co., Ltd. Pyrrolopyridine derivative preparation method
CN118284609A (zh) * 2021-12-01 2024-07-02 St制药株式会社 用于制备三唑并嘧啶酮衍生物的方法
JP2026507361A (ja) * 2023-03-10 2026-03-02 エスティー ファーム カンパニー リミテッド 新規固体分散体およびその製造方法
WO2024191138A1 (ko) * 2023-03-10 2024-09-19 에스티팜 주식회사 트리아졸로피리미디논 유도체와 mek 억제제의 병용 요법
WO2024191139A1 (ko) * 2023-03-10 2024-09-19 에스티팜 주식회사 Kras 변이 암의 예방 또는 치료용 조성물
WO2025084446A1 (ko) * 2023-10-16 2025-04-24 에스티팜 주식회사 트리아졸로피리미디논 유도체의 결정형

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040242568A1 (en) * 2003-03-25 2004-12-02 Syrrx, Inc. Dipeptidyl peptidase inhibitors
US20080242661A1 (en) 2006-12-11 2008-10-02 Graeme James Dykes Novel compounds useful for the treatment of degenerative & inflammatory diseases
MX2014000536A (es) 2011-07-13 2014-12-05 Novartis Ag Compuestos de 4-piperidinilo para usarse como inhibidores de tanquirasa.
PL2831077T3 (pl) 2012-03-28 2016-10-31 Bicykliczne pochodne pirazynonowe
WO2013182546A1 (en) 2012-06-07 2013-12-12 F. Hoffmann-La Roche Ag Pyrazolopyrimidone and pyrazolopyridone inhibitors of tankyrase
KR20150005711A (ko) 2012-06-07 2015-01-14 에프. 호프만-라 로슈 아게 탄키라제 억제제로서 피롤로피리미돈 및 피롤로피리돈

Also Published As

Publication number Publication date
EP3166945B1 (en) 2019-10-09
JP2017521439A (ja) 2017-08-03
CN106488918B (zh) 2020-02-28
ES2763566T3 (es) 2020-05-29
CN106488918A (zh) 2017-03-08
JP6257835B2 (ja) 2018-01-10
US9914737B2 (en) 2018-03-13
DK3166945T3 (da) 2020-01-13
PT3166945T (pt) 2020-01-08
EP3166945A4 (en) 2018-02-14
HUE048394T2 (hu) 2020-07-28
KR101739003B1 (ko) 2017-05-23
EP3166945A2 (en) 2017-05-17
US20170145016A1 (en) 2017-05-25
KR20160007348A (ko) 2016-01-20

Similar Documents

Publication Publication Date Title
IL252216A0 (en) Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines
IL247014A0 (en) 6-heteroaryloxy and 6-aryloxy-quinoline-2-carboxamides and their use
EP3099171A4 (en) Dihydropteridinone derivatives and uses thereof
SG11201608943VA (en) Substituted 4-phenylpiperidines, their preparaiton and use
ZA201703768B (en) Fgf21 derivatives and uses thereof
PL3152226T3 (pl) Modyfikowane cyklopentapeptydy i ich zastosowania
GB201401617D0 (en) Novel combination and use
EP3154972A4 (en) Azamophinan derivatives and use thereof
SG11201609490QA (en) Polymer-flavonoid conjugate and uses thereof
HUE052575T2 (hu) Új kombináció és alkalmazás
PL3157901T3 (pl) Preparaty, ich wytwarzanie i zastosowanie, oraz odpowiednie składniki
EP3177147A4 (en) Dihydropteridinone derivatives and uses thereof
PL3166945T3 (pl) Nowe pochodne triazolopirymidynonu lub triazolopirydynonu i ich zastosowanie
GB201408673D0 (en) Medicaments,uses and methods
IL251335A0 (en) Piperidinylpyrazolopyrimidinones and their use
IL249122A0 (en) History of imidazole- or 4,2,1-triazole and their use
PL3386988T3 (pl) Nowe pochodne dihydropiranopirymidynonu i ich zastosowanie
IL249073A0 (en) Cytin-glucan complex, its preparation and uses
EP3227293A4 (en) 6.7-cyclicmorphinan derivatives and use thereof
EP3187488A4 (en) Novel amino-phenyl-sulfonyl-acetate derivative and use thereof
IL249897B (en) 2-oxo-4,3-dihydropyridine-5-carboxylates and their use
EP3166946A4 (en) Novel imidazotriazinone or imidazopyrazinone derivatives, and use thereof
GB2545167B (en) Cloches and use thereof
PL3229772T3 (pl) 6-arylo-9-glikozylopuryny i ich zastosowanie
GB201500278D0 (en) Novel combination and use